Mühlbacher Axel C, Kaczynski Anika
IGM Institut Gesundheitsökonomie und Medizinmanagement, Hochschule Neubrandenburg, Brodaer Straße 2, 17033, Neubrandenburg, Germany.
Gesellschaft für empirische Beratung GmbH (GEB), Freiburg, Germany.
Appl Health Econ Health Policy. 2016 Feb;14(1):29-40. doi: 10.1007/s40258-015-0203-4.
Healthcare decision making is usually characterized by a low degree of transparency. The demand for transparent decision processes can be fulfilled only when assessment, appraisal and decisions about health technologies are performed under a systematic construct of benefit assessment. The benefit of an intervention is often multidimensional and, thus, must be represented by several decision criteria. Complex decision problems require an assessment and appraisal of various criteria; therefore, a decision process that systematically identifies the best available alternative and enables an optimal and transparent decision is needed. For that reason, decision criteria must be weighted and goal achievement must be scored for all alternatives. Methods of multi-criteria decision analysis (MCDA) are available to analyse and appraise multiple clinical endpoints and structure complex decision problems in healthcare decision making. By means of MCDA, value judgments, priorities and preferences of patients, insurees and experts can be integrated systematically and transparently into the decision-making process. This article describes the MCDA framework and identifies potential areas where MCDA can be of use (e.g. approval, guidelines and reimbursement/pricing of health technologies). A literature search was performed to identify current research in healthcare. The results showed that healthcare decision making is addressing the problem of multiple decision criteria and is focusing on the future development and use of techniques to weight and score different decision criteria. This article emphasizes the use and future benefit of MCDA.
医疗保健决策通常具有透明度较低的特点。只有在健康技术的评估、评价和决策是在效益评估的系统框架下进行时,对透明决策过程的需求才能得到满足。一项干预措施的效益往往是多维度的,因此,必须由几个决策标准来体现。复杂的决策问题需要对各种标准进行评估和评价;因此,需要一个能系统地识别最佳可用方案并实现最优且透明决策的决策过程。出于这个原因,必须对决策标准进行加权,并对所有方案的目标达成情况进行评分。多标准决策分析(MCDA)方法可用于分析和评价多个临床终点,并构建医疗保健决策中的复杂决策问题。通过MCDA,可以将患者、被保险人及专家的价值判断、优先事项和偏好系统且透明地纳入决策过程。本文描述了MCDA框架,并确定了MCDA可能有用的潜在领域(如健康技术的批准、指南制定及报销/定价)。进行了文献检索以识别医疗保健领域的当前研究。结果表明,医疗保健决策正在解决多决策标准的问题,并专注于对不同决策标准进行加权和评分的技术的未来发展与应用。本文强调了MCDA的应用及未来效益。